does tirzepatide speed up your metabolism did not impact metabolic adaptation in people with obesity, but increased fat oxidation does tirzepatide slow metabolism Zepbound

Retatrutide produced 28.7% weight loss at 68 weeks in the TRIUMPH-4 Phase 3 trial, compared to Tirzepatides 22.5% at 72 weeks in SURMOUNT-1

In medical weight loss, commonly used peptide classes include growth-hormonerelated peptides (like AOD9604 or tesamorelin), appetite- and glucose-regulating agents (such as GLP1 analogs), and others that influence insulin sensitivity, inflammation, and body composition

Neuron 22, 221232

Mechanism of Action: GLP-1 receptor agonists work through multiple physiological pathways: Central appetite suppression : These medications cross the blood-brain barrier and activate GLP-1 receptors in the hypothalamus and brainstem, reducing hunger signals and increasing satiety Gastric emptying delay : By slowing stomach emptying, patients experience prolonged fullness after meals Insulin secretion enhancement : Glucose-dependent insulin release improves glycemic control Glucagon suppression : Reduced glucagon secretion decreases hepatic glucose production Tirzepatide offers dual agonism at both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, potentially providing enhanced weight loss efficacy compared to single-agonist medications